| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended waiting and not buying Doximity, adding that it is ...
BMO Capital analyst Sean Dodge initiates coverage on Doximity (NYSE:DOCS) with a Market Perform rating and announces Price T...
Canaccord Genuity analyst Richard Close maintains Doximity (NYSE:DOCS) with a Hold and lowers the price target from $67 to $58.
Risk-off sentiment dominated Wall Street on Friday, with selling pressure in AI-linked names intensifying and pushing technolog...
Evercore ISI Group analyst Elizabeth Anderson maintains Doximity (NYSE:DOCS) with a Outperform and lowers the price target f...
Doximity (NYSE:DOCS) raises FY2026 sales outlook from $628.000 million-$636.000 million to $640.000 million-$646.000 million vs...
Doximity (NYSE:DOCS) sees Q3 sales of $180.000 million-$181.000 million vs $180.671 million analyst estimate.